EPH-101

N/A

Report date: 2025/01/09 11:34:51
NME

Base Information

Drug NameEPH-101
Drug Alias NameEPH-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionErythropoietin-producing hepatocellular receptor A4 modulators
TargetsErythropoietin-producing hepatocellular receptor A4
Therapy Area/IndicationsAmyotrophic Lateral SclerosisFrontotemporal DementiaAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlcyone Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlcyone Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisFrontotemporal DementiaAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A